Exploring the efficacy and biobehavioural basis of Baclofen in the treatment of alcoholic liver disease. [ 2011 - 2016 ]

Research Grant

Researchers: Prof Paul Haber (Principal investigator) ,  A/Pr Kirsten Morley ,  Prof Andrew Baillie

Brief description Alcoholic liver disease (ALD) is the main cause of death from alcohol consumption. Early detection of the disease and subsequent abstinence from alcohol can prevent death and disability. Current medications to help control alcohol consumption are not suitable for use in this patient population owing to the risk of liver side-effects. This study investigates the novel use of an existing medication, baclofen, to safely help maintain abstinence from alcohol in patients suffering from ALD.

Funding Amount $AUD 661,197.53

Funding Scheme Project Grants

Notes Standard Project Grant